EPISODE · Dec 8, 2021 · 27 MIN
A call to action: Global Blood Therapeutics on tackling orphan disease
What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.
Embed this episode
NOW PLAYING
A call to action: Global Blood Therapeutics on tackling orphan disease
0:00
27:33
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 27 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on December 8, 2021.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!